Stock AnalizProto Labs Inc PRLB
Metal Fabrications · IPO 2012 · data as of November 13, 2026
Proto Labs Inc (PRLB) is a industrial company listed in the US with a market value of about $1.6B. In the twelve months to September 30, 2026 it had revenue of $579M and net income of $35M, a net margin of 6.0%.
Its overall Stock Analiz score is 2.2 out of 5 (weak). The strongest part is financial health (5/5); the weakest is value (0/5).
Key numbers: a P/E of 47.2, a price to free cash flow of 33.2, 5-year revenue growth of 4% a year, a 5-year average ROIC of -0%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 63% below the current price.
Score: 2.2 / 5
Checks passed
- Profit margin improving
- 3-year free cash flow growth above 10% a year
- Strong R&D investment or growth above 20%
- More cash than debt, or low debt to equity
- Positive free cash flow
- Interest covered more than 5 times
- Debt below 3 years of free cash flow
- Liabilities below 60% of assets
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- 5-year EPS growth above 10% a year
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $579M | $533M | $501M | $504M | $488M | $488M | $434M | $459M | $446M | $344M | $298M |
| Net income | $35M | $21M | $17M | $17M | -$103M | $33M | $51M | $64M | $77M | $52M | $43M |
| Free cash flow | $49M | $60M | $69M | $45M | $40M | $21M | $60M | $54M | $36M | $49M | $44M |
| EPS (diluted) | $1.43 | $0.88 | $0.66 | $0.66 | $-3.77 | $1.21 | $1.89 | $2.35 | $2.81 | $1.93 | $1.61 |
| Net margin | 6.0% | 4.0% | 3.3% | 3.4% | -21.2% | 6.8% | 11.7% | 13.9% | 17.2% | 15.0% | 14.3% |
| ROIC | — | 2.5% | 2.0% | 2.5% | -11.0% | 4.0% | 7.4% | 10.5% | 13.7% | 10.8% | 10.8% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 4 analysts is $101.25, 50% above the current price; targets range from $91.00 to $110.00; the consensus rating is “Buy”; expected EPS is $2.27 for the fiscal year ending December 31, 2026.
Frequently asked questions
What is Proto Labs’s P/E ratio?
About 47.2, based on the last twelve months of diluted earnings per share (forward P/E about 29.3).
Is Proto Labs stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 63% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Proto Labs pay a dividend?
Not currently.
Is Proto Labs a good stock to buy?
We do not give buy or sell advice. Proto Labs scores 2.2 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.